Cambridge Health Alliance
Cambridge, Massachusetts, 02139, United States
NCT Number: NCT00226356
This study is being conducted to determine the clinical response rate for the regimen of L-methionine, betaine and folate for unipolar depression.
Looking for future studies?
Notify Me18 year–64 year
All sexes
Interventional
Phase 4
Cambridge, Massachusetts, 02139, United States
The study is 6 weeks long, with 9 clinical visits. All visits will take place at our location in Massachusetts.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cambridge Health Alliance
Other
Phase 4 Study: An Open Study of the Efficacy and Tolerability in Unipolar Depression of Augmentation of the One-carbon Cycle With L-methionine, Betaine and Folate
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07599124
Behavior, Behavioral Symptoms
Eindhoven, Netherlands
View Trial DetailsNCT03191058
Behavior, Behavioral Symptoms
San Diego, California, United States
View Trial DetailsNCT04059952
Bipolar Depression, Bipolar Disorder
Boston, Massachusetts, United States
View Trial DetailsNCT04939649
Bipolar Depression, Bipolar Disorder
Dublin, Ireland
View Trial Details